You are currently viewing a new version of our website. To view the old version click .

Antibodies, Volume 8, Issue 2

June 2019 - 13 articles

  • Issues are regarded as officially published after their release is announced to the table of contents alert mailing list .
  • You may sign up for email alerts to receive table of contents of newly released issues.
  • PDF is the official format for papers published in both, html and pdf forms. To view the papers in pdf format, click on the "PDF Full-text" link, and use the free Adobe Reader to open them.

Articles (13)

  • Article
  • Open Access
35 Citations
9,917 Views
19 Pages

Super Potent Bispecific Llama VHH Antibodies Neutralize HIV via a Combination of gp41 and gp120 Epitopes

  • Nika M. Strokappe,
  • Miriam Hock,
  • Lucy Rutten,
  • Laura E. Mccoy,
  • Jaap W. Back,
  • Christophe Caillat,
  • Matthias Haffke,
  • Robin A. Weiss,
  • Winfried Weissenhorn and
  • Theo Verrips

Broad and potent neutralizing llama single domain antibodies (VHH) against HIV-1 targeting the CD4 binding site (CD4bs) have previously been isolated upon llama immunization. Here we describe the epitopes of three additional VHH groups selected from...

  • Article
  • Open Access
13 Citations
7,216 Views
10 Pages

Specificity of Anti-Citrullinated Protein Antibodies in Rheumatoid Arthritis

  • Nicole H. Trier,
  • Bettina E. Holm,
  • Paul R. Hansen,
  • Ole Slot,
  • Henning Locht and
  • Gunnar Houen

Rheumatoid arthritis (RA) is an autoimmune disease of unknown etiology. The majority of individuals with RA are positive for the disease-specific anti-citrullinated protein antibodies (ACPAs). These antibodies are primarily of cross-reactive nature,...

  • Review
  • Open Access
68 Citations
18,234 Views
23 Pages

Therapeutic antibody technology heavily dominates the biologics market and continues to present as a significant industrial interest in developing novel and improved antibody treatment strategies. Many noteworthy advancements in the last decades have...

  • Article
  • Open Access
8 Citations
6,649 Views
9 Pages

EBNA1 IgM-Based Discrimination Between Rheumatoid Arthritis Patients, Systemic Lupus Erythematosus Patients and Healthy Controls

  • Nicole Hartwig Trier,
  • Anette Holck Draborg,
  • Louise Sternbæk,
  • Lone Troelsen,
  • Janni Lisander Larsen,
  • Søren Jacobsen and
  • Gunnar Houen

Epstein–Barr Virus (EBV) has been associated with development of rheumatic connective tissue diseases like rheumatoid arthritis (RA) and systemic lupus erythematosus (SLE) in genetically susceptible individuals. Diagnosis of RA and SLE relies o...

  • Review
  • Open Access
25 Citations
9,370 Views
21 Pages

The antibody era has greatly impacted cancer management in recent decades. Indeed, antibodies are currently applied for both cancer diagnosis and therapy. For example, monoclonal antibodies are the main constituents of several in vitro diagnostics, w...

  • Review
  • Open Access
15 Citations
8,334 Views
25 Pages

Investigational Monoclonal Antibodies in the Treatment of Multiple Myeloma: A Systematic Review of Agents under Clinical Development

  • Ahmad Iftikhar,
  • Hamza Hassan,
  • Nimra Iftikhar,
  • Adeela Mushtaq,
  • Atif Sohail,
  • Nathaniel Rosko,
  • Rajshekhar Chakraborty,
  • Faryal Razzaq,
  • Sonia Sandeep and
  • Jason Neil Valent
  • + 2 authors

Background: Immunotherapy for multiple myeloma (MM) has been the focus in recent years due to its myeloma-specific immune responses. We reviewed the literature on non-Food and Drug Administration (FDA) approved monoclonal antibodies (mAbs) to highlig...

  • Review
  • Open Access
39 Citations
15,434 Views
21 Pages

Targeting the MHC Ligandome by Use of TCR-Like Antibodies

  • Lene Støkken Høydahl,
  • Rahel Frick,
  • Inger Sandlie and
  • Geir Åge Løset

Monoclonal antibodies (mAbs) are valuable as research reagents, in diagnosis and in therapy. Their high specificity, the ease in production, favorable biophysical properties and the opportunity to engineer different properties make mAbs a versatile c...

  • Review
  • Open Access
13 Citations
6,703 Views
11 Pages

Considerable progress has been made in understanding the role of autoantibodies in systemic vasculitides (SV), and consequently testing for anti-neutrophil cytoplasmic antibodies (ANCA), anti-glomerular basement membrane antibodies (anti-GBM), and an...

  • Review
  • Open Access
133 Citations
27,944 Views
18 Pages

The Ligands for Human IgG and Their Effector Functions

  • Steven W. de Taeye,
  • Theo Rispens and
  • Gestur Vidarsson

25 April 2019

Activation of the humoral immune system is initiated when antibodies recognize an antigen and trigger effector functions through the interaction with Fc engaging molecules. The most abundant immunoglobulin isotype in serum is Immunoglobulin G (IgG),...

  • Review
  • Open Access
28 Citations
11,965 Views
21 Pages

11 April 2019

At the 10th Human Genome Mapping (HGM10) Workshop, in New Haven, for the first time, immunoglobulin (IG) or antibody and T cell receptor (TR) variable (V), diversity (D), joining (J), and constant (C) genes were officially recognized as ‘genes&...

of 2

Get Alerted

Add your email address to receive forthcoming issues of this journal.

XFacebookLinkedIn
Antibodies - ISSN 2073-4468